SCHEMBL22601784

SCHEMBL22601784

CC(C)(C)OC(=O)N1C[C@@H](NC(=O)OCc2ccccc2)CC[C@@H]1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
GAA P10253 1/20 0.55
CTSL P07711 1/20 0.51
CTSB P07858 1/20 0.51
CTSK P43235 1/20 0.51
TSHR P16473 1/20 0.50
HSD11B1 P28845 1/20 0.47
DPP4 P27487 6/20 0.46
DPP7 Q9UHL4 6/20 0.46
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
EPHX1 P07099 1/20 0.45
KCNH2 Q12809 3/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
ACHE P22303 2/20 0.45
ABCB1 P08183 1/20 0.44
KLK7 P49862 1/20 0.44
TLR4 O00206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8990082 0.91 ALDH1A1 (0.50) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL1374899 0.91 ALDH1A1 (0.50) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL29200855 0.91 ALDH1A1 (0.50) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL29200858 0.91 ALDH1A1 (0.50) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL24358140 0.90 TSHR (0.49) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL22601765 0.90 ALDH1A1 (0.48) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL21864768 0.85 ALDH1A1 (0.52) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL20299791 0.85 ALDH1A1 (0.52) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL14746164 0.85 KLK7 (0.43) ALDH1A1GAAKMT2AL3MBTL1ABCB1
SCHEMBL14746163 0.85 KLK7 (0.43) ALDH1A1GAAKMT2AL3MBTL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188071-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC INTERNATIONAL GMBH (DE) 2025-06-12 US disclosed
US-12258338-B2 Modulators of the integrated stress response pathway EVOTEC INTERNATIONAL GMBH (DE) 2025-03-25 US disclosed
US-20230391763-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC INTERNATIONAL GMBH (DE) 2023-12-07 US disclosed
CN-116761803-A Modulators of integrated stress response pathways 埃沃特克国际有限责任公司 2023-09-15 CN disclosed
EP-4232447-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY Evotec International GmbH (DE) 2023-08-30 EP disclosed
US-20220227747-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC (UK) LIMITED (GB) 2022-07-21 US disclosed
WO-2022084447-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC INTERNATIONAL GMBH (DE) 2022-04-28 WO disclosed
WO-2020216766-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC INTERNATIONAL GMBH (DE) 2020-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258338-B2 Modulators of the integrated stress response pathway CRHR2, CRHR1, CRH ALDH1A1 1700/4885GAA 2561/4885CTSL 4534/4885
US-20250188071-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY CRHR2, CRHR1, CRH ALDH1A1 1700/4885GAA 2561/4885CTSL 4534/4885
US-20230391763-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY CRH, AVPR1B, CRHR2 ALDH1A1 3614/4885GAA 3152/4885CTSL 4425/4885
US-20220227747-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY CRHR2, CRHR1, CRH ALDH1A1 1700/4885GAA 2561/4885CTSL 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.